tegaserod Zelnorm restricted
Selected indexed studies
- Serotonin 5-HT4 Receptor Agonists. (, 2012) [PMID:31644253]
- Tegaserod: What's Old Is New Again. (Clin Gastroenterol Hepatol, 2022) [PMID:35123085]
- Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias. (Neurogastroenterol Motil, 2018) [PMID:29441683]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Tegaserod: What's Old Is New Again. (2022) pubmed
- Management of the irritable bowel syndrome. (2001) pubmed
- [Irritable bowel syndrome: current treatment options]. (2007) pubmed
- Serotonin 5-HT4 Receptor Agonists. (2012) pubmed
- Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias. (2018) pubmed
- Should We Use Tegaserod for Irritable Bowel Syndrome? (2019) pubmed
- Diagnosis and management of IBS in adults. (2012) pubmed
- Updates on treatment of irritable bowel syndrome. (2008) pubmed
- Benefit-risk assessment of tegaserod in irritable bowel syndrome. (2004) pubmed
- The FDA's decision-making process: isn't it time to temper the principle of protective paternalism? (2008) pubmed